Legal Representation
Attorney
Angela L. Wilson
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 18, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 18, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 16, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 21, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 1, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 8, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 26, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 12, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 8, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain associated with rheumatoid arthritis, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines; all of the foregoing specifically excluding pharmaceutical preparations and substances acting on the central nervous system, pharmaceutical preparations and substances for the treatment and/or management of, sleep disorders, cognitive disorders, narcolepsy, and neurological or psychiatric diseases or disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005